Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Menarini Group
DescriptionNeurokinin 2 (NK2) receptor (TACR2) antagonist
Molecular Target Neurokinin 2 (NK2) receptor (TACR2)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard Indication Gastrointestinal (unspecified)
Indication DetailsTreat gastrointestinal (GI) disorders in infants
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today